Previous studies of total sleep deprivation (TSD) in the rat have show
n an elevation of waking body temperature (T(b)) early in the deprivat
ion period. TSD rats defend this rise behaviorally by selecting warm a
mbient temperatures and autonomically by increasing heat production, t
hus indicating an elevation of thermoregulatory setpoint. Prostaglandi
ns (PGs) can elevate setpoint and T(b). To investigate whether the TSD
-induced rise in setpoint and T(b) was mediated by PGs, aspirin. which
blocks the synthesis of PGs, was administered 100 mg/kg s.q. to 11 TS
D and 13 control (TSC) rats in baseline and deprivation. During baseli
ne. aspirin produced a nonsignificant (0.16-degrees-C) rise across all
rats in waking T(b). For the sampled time period, waking T(b) during
deprivation day 3 was significantly elevated in TSD rats (0.64-degrees
-C, p < 0.01) but not in TSC rats (0.27-degrees-C). Aspirin was admini
stered on deprivation day 4. It produced a fall in waking T(b) in TSD
rats from its deprivation-induced elevation. The difference between th
e response to aspirin during baseline and during deprivation was signi
ficant (-0.25-degrees-C. p < 0.05) for TSD rats but not TSC rats ( 0.1
7-degrees-C). Time awake after aspirin increased significantly (16.2%,
p < 0.05) during baseline and declined nonsignificantly (1.1%) during
deprivation. These data imply that at least part of the rise in T(b)
that is characteristic of TSD is mediated by PGs. To the extent that P
GD2 promotes lower T(b) and sleep in rats but PGE2 has opposite effect
s, the results are consistent with a shift from PGD2 predominance in b
aseline toward PGE2 predominance during TSD. However, the increase in
sleepiness that occurs with sleep deprivation is more consistent with
a shift toward PGD2 predominance.